Stock Market 13 December 2025

Bloom Energy’s stock stayed above last week’s record levels despite pulling back from its intraday high, as AI data-center builders increasingly see electricity supply as a bottleneck. A Bloom survey found 61% of these builders plan to secure their own power if necessary. ITG, a digital infrastructure contractor backed by Oaktree, is launching an IPO of 19.5 million Class A shares at $19 to $22 each, potentially valuing the company at up to $2.67 billion. AbbVie is acquiring Apogee Therapeutics for $135.11 per share in cash, a 49% premium, with the deal expected to close in the third quarter. Apogee’s top eczema drug may reduce injection frequency compared to Dupixent, with Phase 3 trials planned this year. FTSE Russell will finalize new index memberships after Friday’s U.S. close, with rebuilt indexes operating from Monday. SCHD saw renewed investor interest amid falling share prices and mixed ETF flow data, as investors reconsider dividend funds while Treasury yields remain strong and tech stocks fluctuate. CoreWeave and Nebius joined the Nasdaq-100, along with Astera Labs, Rocket Lab, and Teradyne, but both neocloud stocks fell after recent rallies. IBM’s stock decline is attributed to concerns about enterprise AI’s impact on consulting hours, following Accenture’s results, while bulls point to stronger software margins. The VanEck Semiconductor ETF saw $6.93 billion in net inflows in one day, accounting for 32% of all U.S. tech sector ETF inflows. HIVE shares surged 20% after Columbia University researchers used its GPUs in Paraguay for AI training, with tests showing older Nvidia A40 GPUs remain useful. Broadcom shares fell despite JPMorgan’s defense, as investors focus on the company’s ability to secure large-scale AI infrastructure deals.